Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria)

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Current lymphoma staging and follow-up rely on standardized CT-based International Workshop Criteria (IWC).
• FDG-PET (fluorodeoxyglucose-positron emission tomography) offers functional imaging insights.
• The comparability of clinical trials is a key advantage of current CT-based criteria.

Purpose of the Study:

• To review standardized CT-based criteria for lymphoma staging and follow-up.
• To evaluate the current role of FDG-PET in lymphoma management.
• To explore the integration of FDG-PET with CT-based criteria for improved response assessment.

Main Methods:

• Review of existing literature on CT-based criteria (IWC) for lymphoma.
• Analysis of the role and potential of FDG-PET in lymphoma staging and response assessment.
• Discussion of the integration of functional imaging (FDG-PET) with structural imaging (CT).

Main Results:

• CT-based IWC provide standardized criteria crucial for clinical trial comparability.
• Integrated FDG-PET and IWC offer more accurate assessment of treatment response in lymphoma.
• FDG-PET's role challenges the current paradigm in lymphoma management.

Conclusions:

• Integration of FDG-PET into IWC requires further validation in large prospective trials.
• Future lymphoma clinical trials should consider standardized functional criteria for better outcomes.
• A risk-adapted treatment approach for aggressive lymphoma, differentiating responders and non-responders, can be facilitated by functional imaging.